Clinical Imaging
Volume 34, Issue 6 , Pages 448-452 , November 2010

Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10

  • Anuradha Saokar

      Affiliations

    • Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • ,
  • Michael S. Gee

      Affiliations

    • Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • ,
  • Tina Islam

      Affiliations

    • Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • Corresponding Author InformationCorresponding author. Center for Molecular Imaging Research, Department of Radiology, Division of Abdominal Imaging and Intervention, Boston, MA 02114, USA. Tel.: +1 617 724 4266; fax: +1 617 726 4891.
    • ,
  • Peter R. Mueller

      Affiliations

    • Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • ,
  • Mukesh G. Harisinghani

      Affiliations

    • Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    • Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA

Received 28 August 2009 ,Accepted 28 September 2009.

References 

  1. Harisinghani MG, Dixon WT, Saksena MA, Brachtel E, Blezek DJ, Dhawale PJ, et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics. 2004;24:867–878
  2. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology. 2003;228:777–788
  3. Terris MK, Hausdorff J, Freiha FS. Hematolymphoid malignancies diagnosed at the time of radical prostatectomy. J Urol. 1997;158:1457–1459
  4. Eisenberger CF, Walsh PC, Eisenberger MA, Chow NH, Partin AW, Mostwin JL, et al. Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology. 1999;53:175–179
  5. Harris NL, Jaffe ES, Kiebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification—from controversy to consensus: the REAL and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000;11(Suppl 1):S3–S10
  6. Ballester OF, Moscinski L, Spiers A, Balducci L. Non-Hodgkin's lymphoma in the older person: a review. J Am Geriatr Soc. 1993;41:1245–1254
  7. Weir EG, Epstein JI. Incidental small lymphocytic lymphoma/chronic lymphocytic leukemia in pelvic lymph nodes excised at radical prostatectomy. Arch Pathol Lab Med. 2003;127:567–572
  8. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol. 2002;167:1681–1686
  9. Campbell SC, Klein EA, Levin HS, Piedmonte MR. Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology. 1995;46:352–355
  10. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998;160:2015–2019

PII: S0899-7071(09)00313-1

doi: 10.1016/j.clinimag.2009.09.008

Clinical Imaging
Volume 34, Issue 6 , Pages 448-452 , November 2010

Article Tools

* Image Usage & Resolution